Episode 64
Biotech Hangout
00:00
The Unconstitutionality of IRA
"I'm a little disappointed with Pharma. They should have, as soon as IRA was passed, they should have been ready for this," he says. "As venture investors, you can't really predict that early, which ones are going to get approved or be successful in the clinic." But I think we are still going to be looking at what is pharma interested in and how are they going to change their strategies,. That will trickle down, I believe, in early venture strategies", Bruce adds.
Transcript
Play full episode
